View in EDS HTML Full Text PDF Full Text

REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens.

Saved in:
Bibliographic Details
Title: REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens.
Authors: Zhong J; Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States., Jang A; Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States., Abuqayas B; Division of Oncology, Holden Comprehensive Cancer Center, Iowa City, IA 52242, United States., Basu A; Division of Hematology-Oncology, University of Alabama O'Neal Comprehensive Cancer Center, Birmingham, AL 35233, United States., Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, CA 92663, United States., Bhatlapenumarthi V; Division of Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, United States., Bilen MA; Genitourinary Medical Oncology Program, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, United States., Buch D; Department of Solid Tumor Oncology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte 28204, United States., Chang M; Department of Solid Tumor Oncology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte 28204, United States., Chin E; Division of Hematology-Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA 92307, United States., Darabi S; Hoag Family Cancer Institute, Newport Beach, CA 92663, United States., Dhanikonda N; Department of Hematology-Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States., Ghatalia P; Department of Hematology-Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States., Grigg CM; Department of Solid Tumor Oncology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte 28204, United States., Grier AL; Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States., Jindal T; Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States., Jung J; Division of Hematology-Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA 92307, United States., Kilari D; Division of Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, United States., Kumar HLS; Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States., Lee S; Division of Hematology-Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA 92307, United States., Neelands B; Department of Solid Tumor Oncology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte 28204, United States., Pandya C; Division of Hematology-Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA 92307, United States., Pawalek J; Division of Hematology-Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA 92307, United States., Staggers J; Division of Hematology-Oncology, University of Alabama O'Neal Comprehensive Cancer Center, Birmingham, AL 35233, United States., Yildirim A; Genitourinary Medical Oncology Program, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, United States., Zakharia Y; Division of Oncology, Holden Comprehensive Cancer Center, Iowa City, IA 52242, United States., Zarrabi KK; Department of Medical Oncology, Thomas Jefferson Sidney Kimmel Cancer Center, Philadelphia, PA 19107, United States., Zimmerman M; Department of Medical Oncology, Thomas Jefferson Sidney Kimmel Cancer Center, Philadelphia, PA 19107, United States., Sledge G; Caris Life Sciences, Irving, TX 75039, United States., Spetzler D; Caris Life Sciences, Irving, TX 75039, United States., Elliott A; Caris Life Sciences, Irving, TX 75039, United States., McKay RR; Division of Hematology-Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA 92307, United States., Barata PC; Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States.
Source: The oncologist [Oncologist] 2025 Jun 04; Vol. 30 (6).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyaf135